KS

Kumar Shambhu

Active Director Director DIN 08806412
DIN 08806412 First appointment Jul 2020 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2020
Shareholding value •••• Premium profile

About Kumar Shambhu

Data last updated:

Kumar Shambhu is a Director at Biolone Biotech Private Limited (since 2020). The company operates in Trading. Biolone Biotech Private Limited reported revenue of ₹82,985 (FY 2021).

DIN 08806412
Primary Designation Director
Industry Trading
First Appointment 23 Jul 2020
Oldest Company Age 6 yrs
Largest company Biolone Biotech Private Limited · ₹82,985 (FY 2021)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Biolone Biotech Private Limited U51909BR2020PTC047047
Director23 Jul 20202020₹82,985 (FY 2021)Active

Board colleagues of Kumar Shambhu

NameDINCompanyDesignation
Anupam Kumari08806423Biolone Biotech Private LimitedDirector

Directorship timeline

Open interactive timeline →
Biolone Biotech Private Limited
Premium access

Shareholding and investment profile for Kumar Shambhu

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kumar Shambhu

Kumar Shambhu currently holds 1 directorship: Biolone Biotech Private Limited (Director, since 23 Jul 2020, revenue ₹82,985 (FY 2021)).

Kumar Shambhu was first appointed on 23 Jul 2020 as Director at Biolone Biotech Private Limited.

The current boards of Kumar Shambhu's companies include Anupam Kumari (Biolone Biotech Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available